Katarzyna Magiera-Mularz

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 21

Top Venues

Molecules (Basel, Switzerland)

Journal of medicinal chemistry

Expert opinion on therapeutic patents

ACS medicinal chemistry letters

Uniwersytet Jagielloński w Krakowie

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Uniwersytet Jagielloński w Krakowie Oct 01 2017

Poland

PhD :: Faculty of Chemistry

Publications

Atilio Reyes Romero, Katarzyna Kubica, Radoslaw Kitel, Ismael Rodriguez, Katarzyna Magiera-Mularz, Alexander Dömling, Tad A Holak, Ewa Surmiak
Correction: Reyes Romero et al. Computer- and NMR-Aided Design of Small-Molecule Inhibitors of the Hub1 Protein. Molecules 2022, 27 , 8282. Molecules (Basel, Switzerland) 29 (12) (2024)
Wiktor Uzar, Beata Kaminska, Hubert Rybka, Łukasz Skalniak, Katarzyna Magiera-Mularz, Radoslaw Kitel
An updated patent review on PD-1/PD-L1 antagonists (2022-present). Expert opinion on therapeutic patents 34 (8) (2024)
Atilio Reyes Romero, Katarzyna Kubica, Radoslaw Kitel, Ismael Rodriguez, Katarzyna Magiera-Mularz, Alexander Dömling, Tad A Holak, Ewa Surmiak
Correction: Reyes Romero et al. Computer- and NMR-Aided Design of Small-Molecule Inhibitors of the Hub1 Protein. Molecules 2022, 27 , 8282. Molecules (Basel, Switzerland) 29 (12) (2024)
Wiktor Uzar, Beata Kaminska, Hubert Rybka, Łukasz Skalniak, Katarzyna Magiera-Mularz, Radoslaw Kitel
An updated patent review on PD-1/PD-L1 antagonists (2022-present). Expert opinion on therapeutic patents 34 (8) (2024)
Wiktor Uzar, Beata Kaminska, Hubert Rybka, Łukasz Skalniak, Katarzyna Magiera-Mularz, Radoslaw Kitel
An updated patent review on PD-1/PD-L1 antagonists (2022-present). Expert opinion on therapeutic patents (2024)
Ewa Surmiak, Julia Ząber, Jacek Plewka, Grzegorz Wojtanowicz, Justyna Kocik-Krol, Oskar Kruc, Damian Muszak, Ismael Rodriguez, Bogdan M Musielak, Monica Viviano, Sabrina Castellano, Łukasz Skalniak, Katarzyna Magiera-Mularz, Tad A Holak, Justyna Kalinowska-Tłuścik
Solubilizer Tag Effect on PD-L1/Inhibitor Binding Properties for m -Terphenyl Derivatives. ACS medicinal chemistry letters 15 (1) (2023)
Ewa Surmiak, Julia Ząber, Jacek Plewka, Grzegorz Wojtanowicz, Justyna Kocik-Krol, Oskar Kruc, Damian Muszak, Ismael Rodriguez, Bogdan M Musielak, Monica Viviano, Sabrina Castellano, Łukasz Skalniak, Katarzyna Magiera-Mularz, Tad A Holak, Justyna Kalinowska-Tłuścik
Solubilizer Tag Effect on PD-L1/Inhibitor Binding Properties for m -Terphenyl Derivatives. ACS medicinal chemistry letters 15 (1) (2023)
Marta A Ważyńska, Roberto Butera, Marta Requesens, Annechien Plat, Tryfon Zarganes-Tzitzikas, Constantinos G Neochoritis, Jacek Plewka, Lukasz Skalniak, Justyna Kocik-Krol, Bogdan Musielak, Katarzyna Magiera-Mularz, Ismael Rodriguez, Simon N Blok, Marco de Bruyn, Hans W Nijman, Philip H Elsinga, Tad A Holak, Alexander S S Dömling
Design, Synthesis, and Biological Evaluation of 2-Hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 Antagonist and Its Comparison to Available Small Molecular PD-L1 Inhibitors. Journal of medicinal chemistry (2023)
Hua Zhang, Shijia Zhou, Jacek Plewka, Caiyun Wu, Mengyu Zhu, Qimeng Yu, Bogdan M Musielak, Xiao Wang, Annoor Awadasseid, Katarzyna Magiera-Mularz, Yanling Wu, Wen Zhang
Design, Synthesis, and Antitumor Activity Evaluation of 2-Arylmethoxy-4-(2,2'-dihalogen-substituted biphenyl-3-ylmethoxy) Benzylamine Derivatives as Potent PD-1/PD-L1 Inhibitors. Journal of medicinal chemistry (2023)
Radoslaw Kitel, Ismael Rodriguez, Xabier Del Corte, Jack Atmaj, Magdalena Żarnik, Ewa Surmiak, Damian Muszak, Katarzyna Magiera-Mularz, Grzegorz M Popowicz, Tad A Holak, Bogdan M Musielak
Exploring the Surface of the Ectodomain of the PD-L1 Immune Checkpoint with Small-Molecule Fragments. ACS chemical biology 17 (9) (2022)
Atilio Reyes Romero, Katarzyna Kubica, Radoslaw Kitel, Ismael Rodriguez, Katarzyna Magiera-Mularz, Alexander Dömling, Tad A Holak, Ewa Surmiak
Computer- and NMR-Aided Design of Small-Molecule Inhibitors of the Hub1 Protein. Molecules (Basel, Switzerland) 27 (23) (2022)
Atilio Reyes Romero, Katarzyna Kubica, Radoslaw Kitel, Ismael Rodriguez, Katarzyna Magiera-Mularz, Alexander Dömling, Tad A Holak, Ewa Surmiak
Computer- and NMR-Aided Design of Small-Molecule Inhibitors of the Hub1 Protein. Molecules (Basel, Switzerland) 27 (23) (2022)
Stanisław Malicki, Barbara Pucelik, Edyta Żyła, Małgorzata Benedyk-Machaczka, Wojciech Gałan, Anna Golda, Alicja Sochaj-Gregorczyk, Marta Kamińska, João Crispim Encarnação, Barbara Chruścicka, Hans-Peter Marti, Tony Jialiang Chen, Katarzyna Magiera-Mularz, Bartosz Zięba, Tad A Holak, Janusz M Dąbrowski, Anna Czarna, Joanna Kozieł, Piotr Mydel, Grzegorz Dubin
Imaging of Clear Cell Renal Carcinoma with Immune Checkpoint Targeting Aptamer-Based Probe. Pharmaceuticals (Basel, Switzerland) 15 (6) (2022)
Atilio Reyes Romero, Katarzyna Kubica, Radoslaw Kitel, Ismael Rodriguez, Katarzyna Magiera-Mularz, Alexander Dömling, Tad A Holak, Ewa Surmiak
Computer- and NMR-Aided Design of Small-Molecule Inhibitors of the Hub1 Protein. Molecules (Basel, Switzerland) 27 (23) (2022)
Atilio Reyes Romero, Katarzyna Kubica, Radoslaw Kitel, Ismael Rodriguez, Katarzyna Magiera-Mularz, Alexander Dömling, Tad A Holak, Ewa Surmiak
Computer- and NMR-Aided Design of Small-Molecule Inhibitors of the Hub1 Protein. Molecules (Basel, Switzerland) 27 (23) (2022)
Shabnam Shaabani, Louis Gadina, Ewa Surmiak, Zefeng Wang, Bidong Zhang, Roberto Butera, Tryfon Zarganes-Tzitzikas, Ismael Rodriguez, Justyna Kocik-Krol, Katarzyna Magiera-Mularz, Łukasz Skalniak, Alexander S S Dömling, Tad A Holak
Biphenyl Ether Analogs Containing Pomalidomide as Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction. Molecules (Basel, Switzerland) 27 (11) (2022)
Damian Muszak, Ewa Surmiak, Jacek Plewka, Katarzyna Magiera-Mularz, Justyna Kocik-Krol, Bogdan M Musielak, Dominik Sala, Radoslaw Kitel, Malgorzata Stec, Kazimierz Weglarczyk, Maciej Siedlar, Alexander S S Dömling, Łukasz Skalniak, Tad A Holak
Terphenyl-Based Small-Molecule Inhibitors of Programmed Cell Death-1/Programmed Death-Ligand 1 Protein-Protein Interaction. Journal of medicinal chemistry 64 (15) (2021)
Roberto Butera, Marta Ważyńska, Katarzyna Magiera-Mularz, Jacek Plewka, Bogdan M Musielak, Ewa Surmiak, Dominik Sala, Radoslaw Kitel, Marco de Bruyn, Hans W Nijman, Philip H Elsinga, Tad A Holak, Alexander S S Dömling
Design, Synthesis, and Biological Evaluation of Imidazopyridines as PD-1/PD-L1 Antagonists. ACS medicinal chemistry letters 12 (5) (2021)
Ewa Surmiak, Katarzyna Magiera-Mularz, Bogdan M Musielak, Damian Muszak, Justyna Kocik-Krol, Radoslaw Kitel, Jacek Plewka, Tad A Holak, Łukasz Skalniak
PD-L1 Inhibitors: Different Classes, Activities, and Mechanisms of Action. International journal of molecular sciences 22 (21) (2021)
Magdalena Konieczny, Bogdan M Musielak, Justyna Kocik-Krol, Łukasz Skalniak, Dominik Sala, Miroslawa Czub, Katarzyna Magiera-Mularz, Ismael Rodriguez, Maja Myrcha, Malgorzata Stec, Maciej Siedlar, Tad A Holak, Jacek Plewka
Di-bromo-Based Small-Molecule Inhibitors of the PD-1/PD-L1 Immune Checkpoint. Journal of medicinal chemistry 63 (19) (2020)
Bogdan M Musielak, Weronika Janczyk, Ismael Rodriguez, Jacek Plewka, Dominik Sala, Katarzyna Magiera-Mularz, Tad A Holak
Competition NMR for Detection of Hit/Lead Inhibitors of Protein-Protein Interactions. Molecules (Basel, Switzerland) 25 (13) (2020)

Katarzyna Magiera-Mularz.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Katarzyna Magiera-Mularz